References
- MacMahon S, Cutler J A, Furberg C D, et al. The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: A review of randomized controlled trials. Progr Cardiovasc Dis 1986; 29(Suppl 1)99–118
- Weinberger M H. Antihypertensive therapy and lipids: Evidence, mechanisms, and implications. Arch Intern Med 1985; 145: 1102–5
- Roberts W C. Recent studies on the effect of beta blockers on blood lipid levels. Am Heart J 1989; 117: 709–14
- Wikstrand J, Warnold I, Olsson G, et al. Primary prevention with metropolol in patients with hypertension. Mortality results from the MAPHY study. JAMA 1988; 259: 1976
- Psaty B M, Koepsell T D, LoGerfo J P, et al. Beta-blockers and primary prevention of coronary heart disease in patients with high blood pressure. JAMA 1989; 261: 2187–94
- Cruickshank J M, Pennert K, Sörman A E, Thorp J M, Zacharias F M, Zacharias F J. Low mortality from all causes, including myocardial infarction, in well-controlled hypertensives treated with a beta-blocker plus other antihypertensives. J Hypertension 1987; 5: 489–98
- The Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981; 304s: 801–7
- Beta-blocker Heart Attack Trial Research Group. A randomised trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 1982; 247: 1707–14
- Gundersen T, Kjekshus J, Stokke O, Pedersen T. Timolol maleate and HDL cholesterol after myocardial infarction. Eur Heart J 1985; 6: 840–4
- Shulman R S, Hebert P N, Capone R J, McClure D, Hawkins C M, Henderson L O, Saritelli A, Campbell J. Effects of propranolol on blood lipids and lipoproteins in myocardial infarction. Circulation 1983; 67(Suppl 1)19–21
- Olaaon G, Rehnqvist N, Sjögren A, Erhardt L, Lundman T. Long-term treatment with metoprolol after myocardial infarction: Effect on 3 years mortality and morbidity. J Am Coll Cardiol 1985; 5: 1428–37
- Olsson G, Rehnqvist N. Postinfarction metoprolol treatments Effects on prognosis in relation to serum cholesterol concentrations. Cardiology 1987; 74: 457–64
- Henriksson P. Cardiovascular and metabolic effects of exogenous estrogen in patients with prostatic cancer. Doctorial thesis Karolinska Institutet, Stockholm 1986
- Henriksson P, Edhag O. Orchidectomy versus oestrogen for prostatic cancers cardiovascular effects. Br Med J 1986; 293: 413–5
- Lindén T, Bondjers G, Camejo G, et al. Affinity of LDL to human arterial proteoglycan among male survivors of myocardial infarction. Eur J Clin Invest 1989; 19: 38–44
- Lindén T, Camejo G, Wiklund O, . Effect of short-term beta-blockade on serum lipid levels and the interaction of LDL with human arterial proteoglycans A comparison between metoprolol-CR and atenolol. Retention and accumulation of apo-lipoprotein B and lipids in human arterial tissue, T Lindén, et al. Göteborg, Vaaastadens 1988, (ISBN 91-7900-480-69.)(Doctorial thesis)
- Olsson G, Åblad B, Rydén L. Long-term cardiovascular effects of metoprolol therapy. J Clin Pharmacol, in press